Toward a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny – part I: which parameters from human studies are most relevant for toxicological assessments?-Reference-Cited by-同舟云学术

Toward a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny – part I: which parameters from human studies are most relevant for toxicological assessments?

Published:2020-10-20 Issue:9 Volume:50 Page:740-763
ISSN:1040-8444
Container-title:Critical Reviews in Toxicology
language:en
Short-container-title:Critical Reviews in Toxicology

Author:

Sauer Ursula G.¹,Asiimwe Alex²^ORCID,Botham Philip A.³,Charlton Alex³,Hallmark Nina⁴^ORCID,Jacobi Sylvia⁵,Marty Sue⁶^ORCID,Melching-Kollmuss Stephanie⁷,Palha Joana A.⁸⁹¹⁰^ORCID,Strauss Volker⁷^ORCID,van Ravenzwaay Bennard⁷^ORCID,Swaen Gerard¹¹

Affiliation:

1. Scientific Consultancy – Animal Welfare, Neubiberg, Germany

2. Bayer AG, Berlin, Germany

3. Syngenta, Jealott’s Hill, Bracknell, UK

4. Bayer AG, Monheim, Germany

5. Albemarle Europe SRL, Louvain-la-Neuve, Belgium

6. The Dow Chemical Company, Midland, MI, USA

7. BASF SE, Ludwigshafen, Germany

8. Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal

9. ICVS/3B’s, PT Government Associate Laboratory, Guimaraes, Portugal

10. Clinical Academic Center, Braga, Portugal

11. Department of Complex Genetics, Maastricht University, Maastricht, The Netherlands